22.07.2013
- Vivus has agreed to give dissident shareholder First Manhattan a board majority, ending an acrimonious proxy fight and bringing in a new CEO to the drugmaker accused of bungling...
18.07.2013
- Obesity drug maker Vivus, embroiled in a bitter proxy war with its top shareholder First Manhattan, said on Wednesday that FMC had rejected an offer to give the sides equal...
11.07.2013
- QVT Financial, the third-largest shareholder in obesity drugmaker Vivus, intends to vote for the full slate of nine directors proposed by dissident investor First Manhattan, a...
26.06.2013
- First Manhattan Company (FMC) stepped up the pressure in its proxy fight with obesity drug maker Vivus, saying it was in advanced discussions with potential chief executive...
